Neflamapimod
VX-745, a specific and effective inhibitor of p38α(IC50=10 nM), is 22-fold greater specificity against p38β and no inhibition activity to p38γ.
| Catalog Number | T6089 |
| Alternative Name(s) | VX-745 |
| Research Area | Autophagy|||MAPK |
| Molecular Formula | C19H9Cl2F2N3OS |
| CAS# | 209410-46-8 |
| Purity | 99.02% |
| SMILES | c1cc(c(c(c1)Cl)c1c2ccc(nn2cnc1=O)Sc1c(cc(cc1)F)F)Cl |
| Size | 10 mg |
| Supplier Page | https://www.targetmol.com/compound/Neflamapimod |
| Additional Information | https://www.targetmol.com/datasheet/T6089 |